Kim N Chi

20PUBLICATIONS

275CO-AUTHORS

Molecular targetsChemotherapyPharmacogenomicsCancer geneticsPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 02, 2026

Germline CDK12 variants in aggressive prostate cancer.

|Jun 02, 2026

Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.

|Apr 14, 2026

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.

Arun A Azad, Neeraj Agarwal, Andrew J Armstrong

|Feb 26, 2026

Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Jun 20, 2025

ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|Dec 09, 2024

Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

Pageof 4

Frequent Collaborators

Alexander W Wyatt

David Olmos

Joaquin Mateo

Johann S de Bono

Neeraj Agarwal

Ian D Davis

Shahneen Sandhu

Corinne Maurice-Dror

Anders Bjartell

Christian Kollmannsberger

Frequent Collaborators

Alexander W Wyatt

David Olmos

Joaquin Mateo

Johann S de Bono